Andhalea SM, Nikalje APG. Simultaneous estimation of azilsartan and cilnidipine in bulk by RP-HPLC and assessment of its applicability in marketed tablet dosage form. Int J App Pharm, 2022; 14(1):116-23. https://doi.org/10.22159/ijap.2022v14i1.42208 |
|
Desai MM, Nikalje AAG. Quality-by-design based development and validation of stability indicating method by UPLC method for impurities of simvastatin from drug and pharmaceutical dosage form. IJPS, 2021; 83(1):110-9. https://doi.org/10.36468/pharmaceutical-sciences.756 | |
|
Deshmukh S, Vanjari S, Patil R. Application of design of experiment based innovative approach in method development and validation of RP-HPLC for estimation of azilsartan in bulk and pharmaceutical tablet dosage form. Indian J Pharm Educ Res, 2020; 54(3):657-66. https://doi.org/10.5530/ijper.54.3s.165 | |
|
Ghante M, Akhade N, Gota P, Nikam A, Jagtap S, Nikam V. Development and validation of high-performance thin-layer chromatography method for simultaneous estimation of nebivolol hydrochloride and cilnidipine. Asian J Pharm Clin Res, 2019; 12(4):347-50. https://doi.org/10.22159/ajpcr.2019.v12i4.30569 | |
|
ICH. ICH Harmonized Tripartide Guideline: validation of analytical procedure: text and methodology Q2 (R1). ICH, Silver Spring, MD, p 17, 2005. | |
|
Jani R, Patel S. Development and validation of spectrophotometric method for simultaneous estimation of azilsartan kamedoxomil and cilnidipine in synthetic mixture. World J Pharm Res, 2018a; 7(8):948-58. | |
|
Jani R, Patel S. Simultaneous spectrophotometric determination of azilsartan kamedoxomil and cilnidipine in the mixture. Int J Res Pharm Pharm Sci, 2018b; 3(2):86-90. | |
|
Jena BR, Panda SP, Kulandaivelu U, Alavala RR, Rao GSNK, Swain S, Ghose D, Pattnaik G, Pradhan DP. Analytical QbD-based systematic development of a novel RP-UHPLC method for quantification of albuterol sulfate in its metered dose inhaler formulations. J Res Pharm, 2021; 25(5):689-701. https://doi.org/10.29228/jrp.60 | |
|
Juran JM. Juran on quality by design: the new steps for planning quality into goods and services. The Free Press, New York, NY, 1992. | |
|
Kumar H, Begum A. Determination of azilsartan medoximil and chlorthalidone in tablets exposed to forced degradation by using RP-HPLC. Biomed Res, 2019; 30 (5):775-85. https://doi.org/10.35841/biomedicalresearch.30-19-331 | |
|
Khan N, Ameeduzzafar, Ali A, Ahmad FJ. A novel validated stability-indicating HPTLC method to quantitate forskolin as a bulk drug and in a nanosuspension. Indian J Pharm Sci, 2018; 80(5):820-6. https://doi.org/10.4172/pharmaceutical-sciences.1000427 | |
|
Prajapati P, Tailor P, Shahi A, Acharya A, Shah S. Application of Taguchi OA and Box-Behnken design for the implementation of DoE-based AQbD approach to HPTLC method for simultaneous estimation of azilsartan and cilnidipine. J Chromatogr Sci, 2022; 60(5):bmac045. https://doi.org/10.1093/chromsci/bmac045 | |
|
Rathod R, Patil A, Shirkhedkar A. Novel NP, and RP-HPTLC in praxis for simultaneous estimation of chlorthalidone and cilnidipine in bulk and pharmaceutical formulation. J Anal Chem Lett, 2018; 8(6):862-71. https://doi.org/10.1080/22297928.2018.1527252 | |
|
Ruhina T, Mamatha T. A novel RP HPLC method for development and validation of cilnidipine in bulk and pharmaceutical dosage form. Asian Pharm Tech, 2017; 5(14):72-81. | |
|
Solanki RV, Patel RB, Patel RK, Patel BM. Development and validation of fast and robust stability indicating RP-HPLC method for simultaneous estimation of azilsartan medoxomil and cilnidipine in pharmaceutical dosage form. Int J Pharm Investig, 2022; 12(3):293-8. https://doi.org/10.5530/ijpi.2022.3.51 | |
|
Soliman MM, Darwish MK, Abdel-Razeq SA. Determination of amlodipine besylate and azilsartan medoxomil by UHPLC, HPTLC, and spectrophotometric techniques. Int Res J Pure Appl Chem, 2019; 19(3):1- 13. https://doi.org/10.9734/irjpac/2019/v19i330109 | |
|
Sonawane S, Jadhav S, Rahade P, Chhajed S, Kshirsagar S. Development and validation of a stability-indicating method for estimation of chlorthalidone in bulk and tablets with the use of experimental design in forced degradation experiments. Scientifica (Cairo), 2016; 2016:9. https://doi.org/10.1155/2016/4286482 | |
|
Surwade K, Saudagar R. UV Spectrophotometric method for the estimation of azilsartan medoxomil in bulk and pharmaceutical formulations. World J Pharm Res, 2015; 4(1):1667-72. | |
|
U. S. Food and Drug Administration. Guidance for industry: Q8 (2) pharmaceutical development. U. S. Food and Drug Administration, 2009. | |
|
Vyas R, Dediya P, Shah S, Shah D. Development and validation of HPTLC method for estimation of azilsartan medoxomil. Pharma Sci Monit, 2019; 10(1):108-17. | |
|
WHO. Guideline for the pharmacological treatment of hypertension in adults. WHO, Geneva, Switzerland, 2021. | |
|
Yu LX, Amidon G, Khan MA. Understanding pharmaceutical quality by design. AAPS Journal, 2014; 16(4):771-83. https://doi.org/10.1208/s12248-014-9598-3 | |
|
https://go.drugbank.com/drugs/DB08822 (Accessed 21 December 2012). | |
|
https://go.drugbank.com/drugs/DB09232 (Accessed 23 October 2015). | |
|
https://pubchem.ncbi.nlm.nih.gov/compound/Azilsartan | |
|
https://pubchem.ncbi.nlm.nih.gov/compound/Cilnidipine (Accessed March 2005). | |